Headline
The latest stories from AHA Today.
Over 13.8 million people have selected a 2022 health plan through the federally facilitated or state-based marketplaces since open enrollment started Nov. 1, the Centers for Medicare & Medicaid Services announced yesterday.
AHA’s Hospitals Against Violence Initiative, in recognition of National Human Trafficking Awareness Day, today released a digital toolkit with assets that can be used by hospitals and health systems for the entirety of Human Trafficking Prevention Month.
Health Services Research, AHA’s Health Research & Educational Trust’s academic journal, is publishing a special series of articles on reproductive wellness for women with chronic conditions. Abstract proposals are now being sought for these special HSR sections, which will be published…
Health and Human Services Secretary Xavier Becerra today in a letter to health care and public health leaders urged vigilance against cyber threats posed by a vulnerability within the Apache Log4j software. Exploitation of the software, which exists in thousands of applications, including control…
The Food and Drug Administration Jan. 6 issued an outbreak advisory for a multistate outbreak of E. coli O157:H7. FDA said 10 people across Alaska, Ohio, Oregon and Washington have been infected by the strain, with purchase data indicating that seven purchased Nature's Basket Power Greens or Simple…
Former President and CEO of the Ohio Hospital Association James Castle died Jan. 7.
Employment at hospitals and health systems decreased by more than 5,100 jobs in December, as U.S. jobs overall increased by 199,000, according to preliminary data released by the Bureau of Labor Statistics.
The Centers for Medicare & Medicaid Services has approved a new Healthcare Common Procedure Coding System code J0248 for the VEKLURY (remdesivir) antiviral medication when administered in an outpatient setting, following a recent statement from the National Institutes of Health COVID-19…
The Food and Drug Administration announced that five months is the recommended interval between a primary dosing regimen and booster for Moderna’s COVID-19 vaccine. Previously, the recommended gap was six months.
As part of the Consolidated Appropriations Act of 2021, 1,000 new Medicare-funded residency positions will be distributed starting in fiscal year 2023.